GlassScriptPhysician profile
Trevor M Gregath
NPI 1164866976
$763.70
in general payments reported to CMS, 2019-2025
20 companies · $73.72 in 2025
The $73.72 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $89.56 · 2021: $86.66 · 2022: $95.90 · 2023: $227 · 2024: $58.07 · 2025: $73.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $149.38 | 2019-2022 | |
| Medtronic, INC. | $101.88 | 2023 | Linq II |
| Novartis Pharmaceuticals Corporation | $75.20 | 2019-2023 | |
| Abbvie INC. | $73.72 | 2025 | |
| Eisai INC. | $44.32 | 2023-2024 | |
| Lundbeck LLC | $39.54 | 2020-2023 | Vyepti |
| Ani Pharmaceuticals, INC. | $31.75 | 2024 | Purified Cortrophin Gel |
| Medtronic Vascular, INC. | $29.85 | 2019-2020 | |
| Amgen INC. | $25.01 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $23.64 | 2019 | |
| Genzyme Corporation | $22.22 | 2022 | |
| Ge Healthcare | $18.81 | 2023 | |
| Genentech USA, INC. | $18.32 | 2021 | |
| Alexion Pharmaceuticals, INC. | $17.96 | 2023 | Ultomiris |
| Sunovion Pharmaceuticals INC. | $17.23 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impel Pharmaceuticals INC. | $16.98 | 2023 | Trudhesa |
| Livanova USA, INC. | $16.70 | 2022 | |
| Acadia Pharmaceuticals INC | $14.96 | 2023 | Nuplazid |
| Sk Life Science, INC. | $13.69 | 2021 | |
| Biogen, INC. | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Gregath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.